FR2602681B1 - PROCESS FOR THE PREPARATION OF A RECOMBINANT HEPATITIS B VACCINE - Google Patents

PROCESS FOR THE PREPARATION OF A RECOMBINANT HEPATITIS B VACCINE

Info

Publication number: FR2602681B1
Authority: FR; France
Prior art keywords: vaccine; preparation; recombinant hepatitis; hepatitis; recombinant
Prior art date: 1986-08-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR878711426A

Other languages

French (fr)

Other versions

FR2602681A1 (en

Inventor

Igor Viktorovich Krasilnikov

Nikolai Nikolaevich Granovsky

Viktor Mikhailovich Zhdanov

Rem Viktorovich Petrov

Boris Mikhailovich Girdo

Irina Jurievna Kotkova

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

INST IMMUNOLOGII

INST VIRUSOLOGII IVANO

Original Assignee

INST IMMUNOLOGII

INST VIRUSOLOGII IVANO

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-08-13

Filing date

1987-08-11

Publication date

1990-05-18

1987-08-11 Application filed by INST IMMUNOLOGII, INST VIRUSOLOGII IVANO filed Critical INST IMMUNOLOGII

1988-02-19 Publication of FR2602681A1 publication Critical patent/FR2602681A1/en

1990-05-18 Application granted granted Critical

1990-05-18 Publication of FR2602681B1 publication Critical patent/FR2602681B1/en

2007-08-11 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
229940124736 hepatitis-B vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

FR878711426A 1986-08-13 1987-08-11 PROCESS FOR THE PREPARATION OF A RECOMBINANT HEPATITIS B VACCINE Expired - Fee Related FR2602681B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SU864119880A RU1389060C (en)	1986-08-13	1986-08-13	Method of recombinant vaccine to hepatitis

Publications (2)

Publication Number	Publication Date
FR2602681A1 FR2602681A1 (en)	1988-02-19
FR2602681B1 true FR2602681B1 (en)	1990-05-18

Family

ID=21257472

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR878711426A Expired - Fee Related FR2602681B1 (en)	1986-08-13	1987-08-11	PROCESS FOR THE PREPARATION OF A RECOMBINANT HEPATITIS B VACCINE

Country Status (6)

Country	Link
JP (1)	JPS6399021A (en)
CN (1)	CN87106697A (en)
DE (1)	DE3726879A1 (en)
FR (1)	FR2602681B1 (en)
IT (1)	IT1228928B (en)
RU (1)	RU1389060C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69013471T2 (en) *	1989-12-05	1995-03-30	Merck & Co Inc	Method for stabilizing recombinant hepatitis B virus surface proteins from yeast.
CN103012594B (en) *	2011-09-22	2015-09-02	中国农业科学院兰州兽医研究所	A kind of nano-carrier and application delivering pig circular ring virus epitope protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2400365A1 (en) *	1977-08-16	1979-03-16	Pasteur Institut	Purified hepatitis B antigen - obtd. by elimination of beta-lipoprotein, dissociation of complex and denaturing protein contaminants
JPS59101426A (en) *	1982-11-29	1984-06-12	Green Cross Corp:The	Preparation of vaccine for preventing infection of b-type hepatitis
EP0135435A3 (en) *	1983-08-22	1987-03-25	Merck & Co. Inc.	Immunogenic hbsag derived from transformed yeast
JPS60197629A (en) *	1984-03-16	1985-10-07	Chemo Sero Therapeut Res Inst	Method of purification of hbs antigen
US4649192A (en) *	1985-05-30	1987-03-10	Smith Kline-Rit	Method for the isolation and purification of hepatitis B surface antigen using polysorbate
JPS63501121A (en) *	1985-08-15	1988-04-28	アムジエン	Cell lysis method and buffer for extracting hepatitis B surface antigen from yeast cells

1986
- 1986-08-13 RU SU864119880A patent/RU1389060C/en active
1987
- 1987-08-11 FR FR878711426A patent/FR2602681B1/en not_active Expired - Fee Related
- 1987-08-12 JP JP62200080A patent/JPS6399021A/en active Pending
- 1987-08-12 IT IT8721644A patent/IT1228928B/en active
- 1987-08-12 DE DE19873726879 patent/DE3726879A1/en not_active Withdrawn
- 1987-08-13 CN CN198787106697A patent/CN87106697A/en active Pending

Also Published As

Publication number	Publication date
CN87106697A (en)	1988-10-05
FR2602681A1 (en)	1988-02-19
DE3726879A1 (en)	1988-03-03
JPS6399021A (en)	1988-04-30
RU1389060C (en)	1993-06-30
IT8721644A0 (en)	1987-08-12
IT1228928B (en)	1991-07-10

Similar Documents

Publication	Publication Date	Title
MA22894A1 (en)	1993-12-31	PROCESS FOR THE PREPARATION OF A VACCINE.
PT86318A (en)	1988-01-01	Process for the preparation of immunogenic proteins
LTIP1794A (en)	1995-08-25	Method for the production of an aids virus vaccine
HK38293A (en)	1993-04-30	Hepatitis c virus
YU165486A (en)	1989-08-31	Process for obtaining vaccine against aids
HU890720D0 (en)	1990-02-28	Process for the preparation of protein-like water-dispersingable macrocolloides
GB2212511B (en)	1992-01-22	Hepatitis c virus
FR2621785B1 (en)	1993-12-10	PROCESS FOR PREPARING A ROUX
HUT41050A (en)	1987-03-30	Process for preparing synthetic vaccine against foot-and-mouth disease
PT87065A (en)	1988-04-01	PROCESS FOR THE PREPARATION OF A VACCINE AGAINST PASTEURELLOSIS
DE3377972D1 (en)	1988-10-20	A process for producing a hepatitis b infection preventing vaccine
GB2111829B (en)	1985-09-18	A process for the preparation of lyophilized vaccine against duck hepatitis
FR2567540B1 (en)	1988-10-14	PROCESS FOR THE PREPARATION OF A HUMAN LEUKOCYTA INTERFERON ALPHA-2
HU895667D0 (en)	1990-01-28	Process for the preparation of 2-(amino-alkyl-thio)-carbapenems
MA22097A1 (en)	1991-12-31	PROCESS FOR THE PREPARATION OF POLYPEPTIDE AND PROCESS FOR THE MANUFACTURE OF A MALARIA VACCINE.
PT87857A (en)	1988-07-01	PROCESS FOR THE PREPARATION OF NOVEL IMMUNOSSUPRESSANT PEPTIDES
FR2630735B1 (en)	1990-09-14	PROCESS FOR THE PREPARATION OF HALOGENOPHENOLS
FR2633273B1 (en)	1993-06-25	PROCESS FOR THE PREPARATION OF URANIUM TETRAFLURORIDE
FR2602681B1 (en)	1990-05-18	PROCESS FOR THE PREPARATION OF A RECOMBINANT HEPATITIS B VACCINE
AU7713387A (en)	1988-02-18	Hepatitis vaccine
PT83544A (en)	1986-11-01	PROCESS FOR THE PREPARATION OF A LIVE VACCINE AGAINST BRONCHOCELE
HUT43107A (en)	1987-09-28	Process for producing vaccine against melanome
FR2610924B1 (en)	1990-05-04	PROCESS FOR THE PREPARATION OF HYDROXYBIPHENYLES
FR2615185B1 (en)	1990-05-25	PROCESS FOR THE PREPARATION OF TRIFLUOROMETHYLTOLUENE FROM HALOMETHYLBENZOTRIFLUORIDE
GB2181434A (en)	1987-04-23	Hepatitis b virus vaccine and process for its preparation

Legal Events

Date	Code	Title	Description
1992-06-26	ST	Notification of lapse